{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:31Z","timestamp":1792789711030,"version":"4.5.0"},"reference-count":238,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Key Laboratory of Human Performance","award":["11DZ2261100"],"award-info":[{"award-number":["11DZ2261100"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Heart failure represents the terminal stage in the development of many cardiovascular diseases, and its pathological mechanisms are closely related to disturbances in energy metabolism and mitochondrial dysfunction in cardiomyocytes. In recent years, nicotinamide adenine dinucleotide (NAD+), a core coenzyme involved in cellular energy metabolism and redox homeostasis, has been shown to potentially ameliorate heart failure through the regulation of mitochondrial function. This review systematically investigates four core mechanisms of mitochondrial dysfunction in heart failure: imbalance of mitochondrial dynamics, excessive accumulation of reactive oxygen species (ROS) leading to oxidative stress injury, dysfunction of mitochondrial autophagy, and disturbance of Ca2+ homeostasis. These abnormalities collectively exacerbate the progression of heart failure by disrupting ATP production and inducing apoptosis and myocardial fibrosis. NAD+ has been shown to regulate mitochondrial biosynthesis and antioxidant defences through the activation of the deacetylase family (e.g., silent information regulator 2 homolog 1 (SIRT1) and SIRT3) and to increase mitochondrial autophagy to remove damaged mitochondria, thus restoring energy metabolism and redox balance in cardiomyocytes. In addition, the inhibition of NAD+-degrading enzymes (e.g., poly ADP-ribose polymerase (PARP), cluster of differentiation 38 (CD38), and selective androgen receptor modulators (SARMs)) increases the tissue intracellular NAD+ content, and supplementation with NAD+ precursors (e.g., \u03b2-nicotinamide mononucleotide (NMN), nicotinamide riboside, etc.) also significantly elevates myocardial NAD+ levels to ameliorate heart failure. This study provides a theoretical basis for understanding the central role of NAD+ in mitochondrial homeostasis and for the development of targeted therapies for heart failure.<\/jats:p>","DOI":"10.3390\/nu17111855","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:46:26Z","timestamp":1748504786000},"page":"1855","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective"],"prefix":"10.3390","volume":"17","author":[{"given":"Fan","family":"Yu","sequence":"first","affiliation":[{"name":"School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5180-4017","authenticated-orcid":false,"given":"Huiying","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, EYE & ENT Hospital of Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-7363","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Athletic Performance, Shanghai University of Sport, Shanghai 200438, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_5","unstructured":"(2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204\u20131222."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: A comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1573403X11309020005","article-title":"Heart failure epidemiology: European perspective","volume":"9","author":"Guha","year":"2013","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"118685","DOI":"10.1016\/j.jep.2024.118685","article-title":"Jin-Xin-Kang alleviates heart failure by mitigating mitochondrial dysfunction through the Calcineurin\/Dynamin-Related Protein 1 signaling pathway","volume":"335","author":"Lin","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Popa, I.P., Haba M\u0218, C., M\u0103r\u0103nduc\u0103, M.A., T\u0103nase, D.M., \u0218erban, D.N., \u0218erban, L.I., Iliescu, R., and Tudorancea, I. (2022). Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091964"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12986-022-00653-9","article-title":"Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: A meta-analysis","volume":"19","author":"Zhong","year":"2022","journal-title":"Nutr. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","article-title":"Evolving concepts in NAD+ metabolism","volume":"33","author":"Chini","year":"2021","journal-title":"Cell Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature01578","article-title":"Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae","volume":"423","author":"Anderson","year":"2003","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., and Shi, Y. (2023). NAD+ metabolism-based immunoregulation and therapeutic potential. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-01031-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneph.2017.5","article-title":"Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases","volume":"13","author":"Hershberger","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.regpep.2013.07.005","article-title":"Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes","volume":"186","author":"Li","year":"2013","journal-title":"Regul. Pept."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/rej.2019.2218","article-title":"Interacting NAD+ and Cell Senescence Pathways Complicate Antiaging Therapies","volume":"22","author":"Mendelsohn","year":"2019","journal-title":"Rejuvenation Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rotllan, N., Camacho, M., Tondo, M., Diarte-A\u00f1azco, E.M.G., Canyelles, M., M\u00e9ndez-Lara, K.A., Benitez, S., Alonso, N., Mauricio, D., and Escol\u00e0-Gil, J.C. (2021). Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10121939"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1161\/CIRCULATIONAHA.117.032626","article-title":"Raising NAD in Heart Failure: Time to Translate?","volume":"137","author":"Walker","year":"2018","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI24405","article-title":"Mitochondrial energy metabolism in heart failure: A question of balance","volume":"115","author":"Huss","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2018.09.019","article-title":"Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities","volume":"129","author":"Kiyuna","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/ijms.89370","article-title":"NAD+-A Hub of Energy Metabolism in Heart Failure","volume":"21","author":"Wu","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2017.09.001","article-title":"Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure","volume":"112","author":"Zhang","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"H839","DOI":"10.1152\/ajpheart.00409.2017","article-title":"Emerging potential benefits of modulating NAD+ metabolism in cardiovascular disease","volume":"314","author":"Matasic","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/eurheartj\/ehab082","article-title":"The struggle towards a Universal Definition of Heart Failure-how to proceed?","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac Dysfunction, Congestion and Loop Diuretics: Their Relationship to Prognosis in Heart Failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e016900","DOI":"10.1161\/JAHA.120.016900","article-title":"Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death","volume":"9","author":"Shugg","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: Insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/clc.23321","article-title":"Heart failure with preserved ejection fraction: New approaches to diagnosis and management","volume":"43","author":"Upadhya","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_36","unstructured":"Golla, M.S.G., Hajouli, S., and Ludhwani, D. (2025). Heart Failure and Ejection Fraction. StatPearls, StatPearls Publishing."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC. Heart Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Szummer","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2459\/JCM.0000000000000653","article-title":"Characteristics and outcome for heart failure patients with mid-range ejection fraction","volume":"19","author":"Wang","year":"2018","journal-title":"J. Cardiovasc. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"D\u2019Amario, D., Migliaro, S., Borovac, J.A., Restivo, A., Vergallo, R., Galli, M., Leone, A.M., Montone, R.A., Niccoli, G., and Aspromonte, N. (2019). Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01347"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5569410","DOI":"10.1155\/2021\/5569410","article-title":"ACE2 and Apelin-13: Biomarkers with a Prognostic Value in Congestive Heart Failure","volume":"2021","author":"Goidescu","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chiorescu, R.M., Lazar, R.D., Buksa, S.B., Mocan, M., and Blendea, D. (2022). Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.910100"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jjcc.2011.11.014","article-title":"Congestive heart failure in the elderly: Comparison between reduced ejection fraction and preserved ejection fraction","volume":"59","author":"Satomura","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1161\/CIRCRESAHA.115.305765","article-title":"Recent Developments in Heart Failure","volume":"117","author":"Dassanayaka","year":"2015","journal-title":"Circ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2020.10.007","article-title":"Energy metabolism disorders and potential therapeutic drugs in heart failure","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/S0021-9258(18)92956-X","article-title":"Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts","volume":"266","author":"Saddik","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1172\/JCI114616","article-title":"Effects of acute hyperglycemia on myocardial glycolytic activity in humans","volume":"85","author":"Wisneski","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_52","first-page":"1863","article-title":"Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation","volume":"79","author":"Lee","year":"2015","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Karwi, Q.G., Uddin, G.M., Ho, K.L., and Lopaschuk, G.D. (2018). Loss of Metabolic Flexibility in the Failing Heart. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00068"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","article-title":"Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man","volume":"24","author":"Barth","year":"1992","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/01.RES.56.3.377","article-title":"Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts","volume":"56","author":"Schaper","year":"1985","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","article-title":"Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial","volume":"26","author":"Butler","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1015372407647","article-title":"Electron transport chain defects in heart failure","volume":"7","author":"Casademont","year":"2002","journal-title":"Heart Fail. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(00)00011-7","article-title":"Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy","volume":"6","author":"Quigley","year":"2000","journal-title":"J. Card. Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCRESAHA.117.311124","article-title":"Rong Tian: Finding What Feeds the Heart","volume":"120","author":"Jansen","year":"2017","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.2174\/1381612821666150710150445","article-title":"Myocardial Energy Substrate Metabolism in Heart Failure: From Pathways to Therapeutic Targets","volume":"21","author":"Fukushima","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Shu, H., Peng, Y., Hang, W., Zhou, N., and Wang, D.W. (2020). Trimetazidine in Heart Failure. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.569132"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cjca.2017.03.009","article-title":"Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbamcr.2012.08.014","article-title":"Targeting mitochondrial oxidative metabolism as an approach to treat heart failure","volume":"1833","author":"Fillmore","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apsb.2018.05.006","article-title":"Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: Current strategies and future perspectives","volume":"8","author":"Battogtokh","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2011.01.032","article-title":"Targeting mitochondrial oxidative stress in heart failure throttling the afterburner","volume":"58","author":"Maack","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"106038","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: Overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"key":"ref_71","first-page":"266","article-title":"Mitochondrial dynamics and metabolic regulation in cardiac and skeletal muscle","volume":"129","author":"Abel","year":"2018","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_72","first-page":"1447","article-title":"Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Vona, R., Mileo, A.M., and Matarrese, P. (2021). Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer. Cancers, 13.","DOI":"10.3390\/cancers13225812"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","article-title":"Mitochondrial fusion, fission, and mitochondrial toxicity","volume":"391","author":"Meyer","year":"2017","journal-title":"Toxicology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e48395","DOI":"10.15252\/embr.201948395","article-title":"Causal roles of mitochondrial dynamics in longevity and healthy aging","volume":"20","author":"Sharma","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41569-022-00703-y","article-title":"The role of mitochondrial fission in cardiovascular health and disease","volume":"19","author":"Quiles","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41423-020-0480-1","article-title":"The essential functions of mitochondrial dynamics in immune cells","volume":"17","author":"Xie","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2017.09.023","article-title":"Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates Mitochondrial Senescence","volume":"26","author":"Song","year":"2017","journal-title":"Cell Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","article-title":"Mitochondrial Structure and Function in Human Heart Failure","volume":"135","author":"Hinton","year":"2024","journal-title":"Circ. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","article-title":"Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide","volume":"32","author":"Sabbah","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","article-title":"The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage","volume":"21","author":"Varanita","year":"2015","journal-title":"Cell Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCRESAHA.110.236745","article-title":"MARF and Opa1 control mitochondrial and cardiac function in Drosophila","volume":"108","author":"Dorn","year":"2011","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"aad0116","DOI":"10.1126\/science.aad0116","article-title":"Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice","volume":"350","author":"Wai","year":"2015","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e003012","DOI":"10.1161\/JAHA.112.003012","article-title":"OPA1 mutation and late-onset cardiomyopathy: Mitochondrial dysfunction and mtDNA instability","volume":"1","author":"Chen","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/dna.2019.4731","article-title":"Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2","volume":"38","author":"Sun","year":"2019","journal-title":"DNA Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCRESAHA.116.303356","article-title":"Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress","volume":"116","author":"Ikeda","year":"2015","journal-title":"Circ. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/JP271301","article-title":"Mitochondrial dynamics, mitophagy and cardiovascular disease","volume":"594","author":"Pennanen","year":"2016","journal-title":"J. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9825061","DOI":"10.1155\/2019\/9825061","article-title":"Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"101129","DOI":"10.1016\/j.arr.2020.101129","article-title":"Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing","volume":"62","author":"Ajoolabady","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"100822","DOI":"10.1016\/j.mam.2019.09.006","article-title":"Emerging role of mitophagy in cardiovascular physiology and pathology","volume":"71","author":"Morales","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-015-1254-6","article-title":"Mitophagy and heart failure","volume":"93","author":"Shires","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"De Gaetano, A., Gibellini, L., Zanini, G., Nasi, M., Cossarizza, A., and Pinti, M. (2021). Mitophagy and Oxidative Stress: The Role of Aging. Antioxidants, 10.","DOI":"10.3390\/antiox10050794"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Kura, B., Szeiffova Bacova, B., Kalocayova, B., Sykora, M., and Slezak, J. (2020). Oxidative Stress-Responsive MicroRNAs in Heart Injury. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010358"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.apsb.2020.09.001","article-title":"Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics","volume":"11","author":"Dolivo","year":"2021","journal-title":"Acta Pharm. Sinica B"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"300060519896143","DOI":"10.1177\/0300060519896143","article-title":"Involvement of phosphatase and tensin homolog-induced putative kinase 1\/Parkin-mediated autophagy in angiotensin II-induced cardiac hypertrophy in C57BL\/6 mice","volume":"48","author":"Fan","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R., and Youle, R.J. (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000298"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.1106291108","article-title":"PTEN-inducible kinase 1 (PINK1)\/Park6 is indispensable for normal heart function","volume":"108","author":"Billia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1074\/jbc.M112.411363","article-title":"Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction","volume":"288","author":"Kubli","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: Past, present and future","volume":"21","author":"Voors","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., and Guo, X. (2022). Mitochondrial dysfunction in heart failure and its therapeutic implications. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.945142"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014A step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1089\/ars.2012.4550","article-title":"NADPH oxidases in heart failure: Poachers or gamekeepers?","volume":"18","author":"Zhang","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","article-title":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications","volume":"36","author":"Gori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1074\/jbc.M209793200","article-title":"Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1161\/01.CIR.96.10.3610","article-title":"Pulsatile stretch stimulates superoxide production in human aortic endothelial cells","volume":"96","author":"Hishikawa","year":"1997","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.107.162800","article-title":"Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction","volume":"102","author":"Doughan","year":"2008","journal-title":"Circ. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","article-title":"Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy","volume":"104","author":"Cappola","year":"2001","journal-title":"Circulation"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"ref_112","first-page":"291","article-title":"Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats","volume":"148","author":"Hill","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0735-1097(96)00574-8","article-title":"Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats","volume":"29","author":"Khaper","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1025448908694","article-title":"Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction","volume":"251","author":"Khaper","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10741-012-9340-0","article-title":"Mitochondrial dysfunction in heart failure","volume":"18","author":"Rosca","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.freeradbiomed.2011.06.011","article-title":"Oxidases and peroxidases in cardiovascular and lung disease: New concepts in reactive oxygen species signaling","volume":"51","author":"Khoo","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.tcb.2018.01.002","article-title":"Calcium Dynamics as a Machine for Decoding Signals","volume":"28","author":"Giorgi","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10741-009-9146-x","article-title":"Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart","volume":"14","author":"Lehnart","year":"2009","journal-title":"Heart Fail. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: Mechanisms: Part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.arr.2007.12.003","article-title":"Altered Ca2+ sparks in aging skeletal and cardiac muscle","volume":"7","author":"Weisleder","year":"2008","journal-title":"Ageing Res. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/s41467-019-12103-x","article-title":"Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation","volume":"10","author":"Lombardi","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00109-010-0663-9","article-title":"Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease","volume":"88","author":"Ren","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41401-020-0476-5","article-title":"Mitochondrial Ca2+ regulation in the etiology of heart failure: Physiological and pathophysiological implications","volume":"41","author":"Xu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","article-title":"Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association","volume":"118","author":"Murphy","year":"2016","journal-title":"Circ. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbabio.2008.05.449","article-title":"The versatility of mitochondrial calcium signals: From stimulation of cell metabolism to induction of cell death","volume":"1777","author":"Rimessi","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbabio.2010.02.022","article-title":"The ups and downs of mitochondrial calcium signalling in the heart","volume":"1797","author":"Griffiths","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ceca.2016.04.005","article-title":"Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy","volume":"60","author":"Roest","year":"2016","journal-title":"Cell Calcium"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4161\/auto.25367","article-title":"Ca2+ in quality control: An unresolved riddle critical to autophagy and mitophagy","volume":"9","author":"East","year":"2013","journal-title":"Autophagy"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.celrep.2016.07.082","article-title":"PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development","volume":"16","author":"Missiroli","year":"2016","journal-title":"Cell Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2010.06.007","article-title":"Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria","volume":"142","author":"Miller","year":"2010","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2023.05.003","article-title":"Heart Failure and Obesity: The Latest Pandemic","volume":"78","author":"Aryee","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: A link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15420\/cfr.2016:20:2","article-title":"Heart Failure in Patients with Diabetes Mellitus","volume":"3","author":"Rosano","year":"2017","journal-title":"Card. Fail. Rev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1152\/ajpendo.00449.2013","article-title":"(Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice","volume":"307","author":"Fukushima","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e34906","DOI":"10.1097\/MD.0000000000034906","article-title":"Heart failure and diabetes: Understanding the bidirectional relationship","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e008170","DOI":"10.1161\/CIRCHEARTFAILURE.120.008170","article-title":"NAD+ Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy","volume":"14","author":"Chiao","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Hong, W., Mo, F., Zhang, Z., Huang, M., and Wei, X. (2020). Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00246"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7555\/JBR.36.20220078","article-title":"SIRT3 regulates mitochondrial biogenesis in aging-related diseases","volume":"37","author":"Li","year":"2022","journal-title":"J. Biomed. Res."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Li, W., Zhou, Y., Pang, N., Hu, Q., Li, Q., Sun, Y., Ding, Y., Gu, Y., Xiao, Y., and Gao, M. (2022). NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial Function. Nutrients, 15.","DOI":"10.3390\/nu15010174"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"110309","DOI":"10.1016\/j.cellsig.2022.110309","article-title":"Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast","volume":"94","author":"Bugga","year":"2022","journal-title":"Cell. Signal."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"326rv323","DOI":"10.1126\/scitranslmed.aac7410","article-title":"Novel targets for mitochondrial medicine","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s12276-022-00739-7","article-title":"Sirtuins are crucial regulators of T cell metabolism and functions","volume":"54","author":"Hamaidi","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","article-title":"Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin","volume":"16","author":"Vaquero","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","article-title":"Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging","volume":"173","author":"Das","year":"2018","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Feige","year":"2009","journal-title":"Nature"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cvr\/cvaa298","article-title":"Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure","volume":"117","author":"Nakamura","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1128\/MCB.01636-07","article-title":"Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation","volume":"27","author":"Lombard","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Finley, L.W., Haas, W., Desquiret-Dumas, V., Wallace, D.C., Procaccio, V., Gygi, S.P., and Haigis, M.C. (2011). Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023295"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ Redox Balance as a Therapy for Heart Failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Noh, M.R., Kong, M.J., Han, S.J., Kim, J.I., and Park, K.M. (2020). Isocitrate dehydrogenase 2 deficiency aggravates prolonged high-fat diet intake-induced hypertension. Redox Biol., 34.","DOI":"10.1016\/j.redox.2020.101548"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jbmr.2974","article-title":"SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.M112.355206","article-title":"SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status","volume":"287","author":"Yu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"914","DOI":"10.18632\/aging.100252","article-title":"Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy","volume":"2","author":"Hafner","year":"2010","journal-title":"Aging"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4161\/auto.24795","article-title":"Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction","volume":"9","author":"Rimessi","year":"2013","journal-title":"Autophagy"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acssynbio.8b00485","article-title":"A Regulatory NADH\/NAD+ Redox Biosensor for Bacteria","volume":"8","author":"Liu","year":"2019","journal-title":"ACS Synth. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000338628","article-title":"Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress","volume":"90","author":"Tong","year":"2012","journal-title":"Pharmacology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCRESAHA.111.247924","article-title":"Overview of pyridine nucleotides review series","volume":"111","author":"Nakamura","year":"2012","journal-title":"Circ. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/acel.12461","article-title":"Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice","volume":"15","author":"Gano","year":"2016","journal-title":"Aging Cell"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jnr.24397","article-title":"Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice","volume":"97","author":"Klimova","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Mehmel, M., Jovanovi\u0107, N., and Spitz, U. (2020). Nicotinamide Riboside-The Current State of Research and Therapeutic Uses. Nutrients, 12.","DOI":"10.3390\/nu12061616"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacbts.2024.01.011","article-title":"The Efficacy of Risk Factor Modification Compared to NAD+ Repletion in Diastolic Heart Failure","volume":"9","author":"Koay","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.03.012","article-title":"Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1\u03b1-PPAR\u03b1 pathway","volume":"183","author":"Hu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/eurheartj\/ehaf062","article-title":"Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction","volume":"46","author":"Abdellatif","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"113043","DOI":"10.1016\/j.celrep.2023.113043","article-title":"The malate-aspartate shuttle is important for de novo serine biosynthesis","volume":"42","author":"Broeks","year":"2023","journal-title":"Cell Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cvr\/cvr051","article-title":"Metabolic fingerprint of ischaemic cardioprotection: Importance of the malate-aspartate shuttle","volume":"91","author":"Nielsen","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2014.11.030","article-title":"The role of Pyruvate Dehydrogenase Complex in cardiovascular diseases","volume":"121","author":"Sun","year":"2015","journal-title":"Life Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.111.246371","article-title":"Pyridine nucleotide regulation of cardiac intermediary metabolism","volume":"111","author":"Ussher","year":"2012","journal-title":"Circ. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/cvr\/cvy033","article-title":"Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury","volume":"114","author":"Wang","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"H53","DOI":"10.1152\/ajpheart.01057.2001","article-title":"Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts","volume":"283","author":"Riess","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"120182","DOI":"10.1172\/jci.insight.120182","article-title":"Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock","volume":"3","author":"Sims","year":"2018","journal-title":"JCI Insight"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Lee, C.F., Caudal, A., Abell, L., Nagana Gowda, G.A., and Tian, R. (2019). Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-39419-4"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Airhart, S.E., Shireman, L.M., Risler, L.J., Anderson, G.D., Nagana Gowda, G.A., Raftery, D., Tian, R., Shen, D.D., and O\u2019Brien, K.D. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186459"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2018.12.087","article-title":"Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload","volume":"73","author":"Smyrnias","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2021.12.015","article-title":"Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice","volume":"165","author":"Liu","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction","volume":"128","author":"Tong","year":"2021","journal-title":"Circ. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature10992","article-title":"Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure","volume":"485","author":"Oka","year":"2012","journal-title":"Nature"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"H1847","DOI":"10.1152\/ajpheart.00203.2011","article-title":"Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model","volume":"302","author":"Zang","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","article-title":"Reactive oxygen species and mitochondria: A nexus of cellular homeostasis","volume":"6","author":"Alvarez","year":"2015","journal-title":"Redox Biol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2018.05.073","article-title":"Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis","volume":"123","author":"Hong","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1172\/JCI138538","article-title":"Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure","volume":"130","author":"Zhou","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cmet.2014.06.001","article-title":"SnapShot: Sirtuins, NAD, and aging","volume":"20","author":"Nakagawa","year":"2014","journal-title":"Cell Metab."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","article-title":"Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice","volume":"24","author":"Mills","year":"2016","journal-title":"Cell Metab."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e202302116","DOI":"10.26508\/lsa.202302116","article-title":"Improving lysosomal ferroptosis with NMN administration protects against heart failure","volume":"6","author":"Yagi","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2013.07.002","article-title":"Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure","volume":"18","author":"Karamanlidis","year":"2013","journal-title":"Cell Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e93885","DOI":"10.1172\/jci.insight.93885","article-title":"Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich\u2019s ataxia cardiomyopathy model","volume":"2","author":"Martin","year":"2017","journal-title":"JCI Insight"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Bharathi, S.S., Beck, M.E., and Goetzman, E.S. (2019). The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide. Redox Biol., 26.","DOI":"10.1016\/j.redox.2019.101253"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.HYP.0000144292.69599.0c","article-title":"Mechanisms for increased glycolysis in the hypertrophied rat heart","volume":"44","author":"Nascimben","year":"2004","journal-title":"Hypertension"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose Metabolism in Cardiac Hypertrophy and Heart Failure","volume":"8","author":"Tran","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yjmcc.2018.06.007","article-title":"Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH","volume":"121","author":"Nadtochiy","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_203","first-page":"990","article-title":"Niacin versus niacinamide","volume":"147","author":"Jaconello","year":"1992","journal-title":"CMAJ Can. Med. Assoc. J. J. L\u2019association Medicale Can."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/1878-0261.13209","article-title":"Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: Potential for drug repositioning as an anti-tumor agent","volume":"16","author":"Jung","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"van Ommen, A., Canto, E.D., Cramer, M.J., Rutten, F.H., Onland-Moret, N.C., and Ruijter, H.M.D. (2022). Diastolic dysfunction and sex-specific progression to HFpEF: Current gaps in knowledge and future directions. BMC Med., 20.","DOI":"10.1186\/s12916-022-02650-4"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"eabd7064","DOI":"10.1126\/scitranslmed.abd7064","article-title":"Nicotinamide for the treatment of heart failure with preserved ejection fraction","volume":"13","author":"Abdellatif","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"113614","DOI":"10.1016\/j.yexcr.2023.113614","article-title":"AMP-activated protein kinase: An energy sensor and survival mechanism in the reinstatement of metabolic homeostasis","volume":"428","author":"Sharma","year":"2023","journal-title":"Exp. Cell Res."},{"key":"ref_209","first-page":"1797","article-title":"Nicotinamide pretreatment alleviates mitochondrial stress and protects hypoxic myocardial cells via AMPK pathway","volume":"23","author":"Lai","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: A pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1080\/15548627.2015.1106668","article-title":"MTOR, PIK3C3, and autophagy: Signaling the beginning from the end","volume":"11","author":"Munson","year":"2015","journal-title":"Autophagy"},{"key":"ref_212","first-page":"5503","article-title":"Nicotinamide protects chronic hypoxic myocardial cells through regulating mTOR pathway and inducing autophagy","volume":"23","author":"Li","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12937-024-01027-y","article-title":"Niacin intake and mortality (total and cardiovascular disease) in patients with cardiovascular disease: Insights from NHANES 2003\u20132018","volume":"23","author":"Yang","year":"2024","journal-title":"Nutr. J."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Gasperi, V., Sibilano, M., Savini, I., and Catani, M.V. (2019). Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040974"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40842-016-0024-x","article-title":"Lipoprotein (a), an independent cardiovascular risk marker","volume":"2","author":"Saeedi","year":"2016","journal-title":"Clin. Diabetes Endocrinol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2012.10.030","article-title":"The current state of niacin in cardiovascular disease prevention: A systematic review and meta-regression","volume":"61","author":"Lavigne","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12937-024-00993-7","article-title":"Dietary niacin Intake and its association with all-cause and cardiovascular mortality rates in individuals with metabolic syndrome","volume":"23","author":"Fu","year":"2024","journal-title":"Nutr. J."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"959","DOI":"10.31925\/farmacia.2018.6.5","article-title":"Effects of nicotinic acid on protein oxidative modifications in experimental chronic heart failure","volume":"66","author":"Nizhenkovska","year":"2018","journal-title":"Farmacia"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tips.2018.02.001","article-title":"The Pharmacology of CD38\/NADase: An Emerging Target in Cancer and Diseases of Aging","volume":"39","author":"Chini","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/jcmm.13076","article-title":"CD38 promotes angiotensin II-induced cardiac hypertrophy","volume":"21","author":"Guan","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.116.239459","article-title":"Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H)","volume":"361","author":"Boslett","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.bmcl.2011.05.022","article-title":"Flavonoids as inhibitors of human CD38","volume":"21","author":"Kellenberger","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Esp\u00edrito-Santo, D.A., Cordeiro, G.S., Santos, L.S., Silva, R.T., Pereira, M.U., Matos, R.J.B., Boaventura, G.T., and Barreto-Medeiros, J.M. (2023). Cardioprotective effect of the quercetin on cardiovascular remodeling and atherosclerosis in rodents fed a high-fat diet: A systematic review. Chem.-Biol. Interact., 384.","DOI":"10.1016\/j.cbi.2023.110700"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism","volume":"23","author":"Chini","year":"2016","journal-title":"Cell Metab."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db12-1139","article-title":"Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome","volume":"62","author":"Escande","year":"2013","journal-title":"Diabetes"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.18632\/aging.103410","article-title":"CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+\/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats","volume":"12","author":"Ogura","year":"2020","journal-title":"Aging"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","article-title":"A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline","volume":"27","author":"Chini","year":"2018","journal-title":"Cell Metab."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1124\/jpet.118.254557","article-title":"Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury","volume":"369","author":"Boslett","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"E6271","DOI":"10.1073\/pnas.1601506113","article-title":"SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation","volume":"113","author":"Summers","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD+ destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Tentori, L., Ricci-Vitiani, L., Muzi, A., Ciccarone, F., Pelacchi, F., Calabrese, R., Runci, D., Pallini, R., Caiafa, P., and Graziani, G. (2014). Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-151"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Wicik, Z., Nowak, A., Jarosz-Popek, J., Wolska, M., Eyileten, C., Siller-Matula, J.M., von Lewinski, D., Sourij, H., Filipiak, K.J., and Postu\u0142a, M. (2022). Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.901340"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Lin, Y.H., Tsai, W.C., Chiu, C.C., Chi, N.Y., Liu, Y.H., Huang, T.C., Wu, W.T., Lin, T.H., Lai, W.T., and Sheu, S.H. (2024). The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1\/SIRT3 and Cascade Signaling. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158541"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/HYPERTENSIONAHA.116.07709","article-title":"Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity","volume":"68","author":"Gao","year":"2016","journal-title":"Hypertension"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s00125-021-05431-5","article-title":"Fasting and fasting-mimicking treatment activate SIRT1\/LXR\u03b1 and alleviate diabetes-induced systemic and microvascular dysfunction","volume":"64","author":"Hammer","year":"2021","journal-title":"Diabetologia"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"e12491","DOI":"10.1111\/jpi.12491","article-title":"Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1\u03b1 pathway","volume":"65","author":"Ding","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/eurheartj\/ehq107","article-title":"SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis","volume":"31","author":"Stein","year":"2010","journal-title":"Eur. Heart J."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/11\/1855\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:42:59Z","timestamp":1760031779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/11\/1855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":238,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["nu17111855"],"URL":"https:\/\/doi.org\/10.3390\/nu17111855","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}